Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Mead

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Urology|September 29, 1998
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk groupS J Harland, P A Cook, S D Fossa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohortR Cathomas, D Klingbiel, T R Geldart, et al.
Cell Biophysics|January 1, 1994
Mechanisms in removal of tumor by antibodyG T Stevenson, A J Bell, T R Evans, et al.
Cancer|March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumorsS D Fosså, C Bokemeyer, A Gerl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working PartyG M Mead, S P Stenning, M C Parkinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's diseaseP D Simmonds, G M Mead, J W Sweetenham, et al.
British Journal of Cancer|October 29, 1998
A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working PartyG M Mead, M Russell, P Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research CouncilR de Wit, J T Roberts, P M Wilkinson, et al.
Progress in Clinical and Biological Research|January 1, 1990
Prognostic factors in metastatic germ cell tumorsG Stoter, G J Bosl, J P Droz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trialC J Williams, G M Mead, F R Macbeth, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Urology|September 29, 1998
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk groupS J Harland, P A Cook, S D Fossa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohortR Cathomas, D Klingbiel, T R Geldart, et al.
Cell Biophysics|January 1, 1994
Mechanisms in removal of tumor by antibodyG T Stevenson, A J Bell, T R Evans, et al.
Cancer|March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumorsS D Fosså, C Bokemeyer, A Gerl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working PartyG M Mead, S P Stenning, M C Parkinson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
PACE BOM chemotherapy: a 12-week regimen for advanced Hodgkin's diseaseP D Simmonds, G M Mead, J W Sweetenham, et al.
British Journal of Cancer|October 29, 1998
A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working PartyG M Mead, M Russell, P Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research CouncilR de Wit, J T Roberts, P M Wilkinson, et al.
Progress in Clinical and Biological Research|January 1, 1990
Prognostic factors in metastatic germ cell tumorsG Stoter, G J Bosl, J P Droz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trialC J Williams, G M Mead, F R Macbeth, et al.
Pageof 13